Development of HPV58 type-specific antibodies and detection kit

References

• Serrano, B.; Brotons, M.; Bosch, F. X.; Bruni, L. Epidemiology and Burden of HPV-Related Disease. Best Pract. Res. Clin. Obstet. Gynaecol. 2018, 47, 14–26. DOI: 10.1016/j.bpobgyn.2017.08.006.
   PubMed Web of Science ®Google Scholar
• Brisson, M.; Kim, J. J.; Canfell, K.; Drolet, M.; Gingras, G.; Burger, E. A.; Martin, D.; Simms, K. T.; Benard, E.; Boily, M. C.; et al. Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination: A Comparative Modelling Analysis in 78 Low-Income and Lower-Middle-Income Countries. Lancet 2020, 395, 575–590. DOI: 10.1016/S0140-6736(20)30068-4.
   PubMed Web of Science ®Google Scholar
• Canfell, K.; Kim, J.; Brisson, M.; Keane, A.; Simms, K. T.; Caruana, M.; Burger, E. A.; Martin, D.; Nguyen, D.; Benard, E.; et al. Mortality Impact of Achieving WHO Cervical Cancer Elimination Targets: A Comparative Modelling Analysis in 78 Low-Income and Lower-Middle-Income Countries. Lancet 2020, 395, 591–603. DOI: 10.1016/S0140-6736(20)30157-4.
   PubMed Web of Science ®Google Scholar
• Sung, H.; Ferlay, J.; Siegel, R. L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2020, 71, 209–249.
   Web of Science ®Google Scholar
• Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A. Global Cancer Statistics 2018: GLOB OCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 68, 394–424. DOI: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• FUTURE II Study Group. Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions. N. Engl. J. Med. 2007, 356, 1915–1927.
   PubMed Web of Science ®Google Scholar
• Paavonen, J.; Naud, P.; Salmerón, J.; Wheeler, C. M.; Chow, S. N.; Apter, D.; Kitchener, H.; Castellsague, X.; Teixeira, J. C.; Skinner, S. R.; et al. Efficacy of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine against Cervical Infection and Precancer Caused by Oncogenic HPV Types (PATRICIA): Final Analysis of a Double-Blind, Randomised Study in Young Women. Lancet 2009, 374, 301–314.
   PubMed Web of Science ®Google Scholar
• Joura, E. A.; Giuliano, A. R.; Iversen, O. E.; Bouchard, C.; Mao, C.; Mehlsen, J.; Moreira, E. D.; Ngan, Y.; Petersen, L. K.; Lazcano-Ponce, E.; et al. A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women. N. Engl. J. Med. 2015, 372, 711–723.
   PubMed Web of Science ®Google Scholar
• Kavanagh, K.; Pollock, K. G.; Cuschieri, K.; Palmer, T.; Cameron, R. L.; Watt, C.; Bhatia, R.; Moore, C.; Cubie, H.; Cruickshank, M.; Robertson, C. Changes in the Prevalence of Human Papillomavirus following a National Bivalent Human Papillomavirus Vaccination Programme in Scotland: A 7-Year Cross-Sectional Study. Lancet Infect. Dis. 2017, 17, 1293–1302.
   PubMed Web of Science ®Google Scholar
• Drolet, M.; Benard, E.; Perez, N.; Brisson, M. Population-Level Impact and Herd Effects following the Introduction of Human Papillomavirus Vaccination Programmes: Updated Systematic Review and Meta-Analysis. Lancet 2019, 394, 497–509.
   PubMed Web of Science ®Google Scholar
• Brown, M. J.; Seitz, H.; Towne, V.; Muller, M.; Finnefrock, A. C. Development of Neutralizing Monoclonal Antibodies for Oncogenic Human Papillomavirus Types 31, 33, 45, 52, and 58. Clin. Vaccine Immunol. 2014, 21, 587–593.
   PubMed Web of Science ®Google Scholar
• Dias, D.; Van Doren, J.; Schlottmann, S.; Kelly, S.; Puchalski, D.; Ruiz, W.; Boerckel, P.; Kessler, J.; Antonello, J. M.; Green, T.; et al. Optimization and Validation of a Multiplexed Luminex Assay to Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18. Clin. Diagn. Lab. Immunol. 2005, 12, 959–969.
   PubMedGoogle Scholar
• Pastrana, D. V.; Buck, C. B.; Pang, Y.; Thompson, C. D.; Castle, P. E.; FitzGerald, P. C.; Kjaer, S. K.; Lowy, D. R.; Schiller, J. T. Reactivity of Human Sera in a Sensitive, High-Throughput Pseudovirus-Based Papillomavirus Neutralization Assay for HPV16 and HPV18. Virology 2004, 321, 205–216. DOI: 10.1016/j.virol.2003.12.027.
   PubMed Web of Science ®Google Scholar
• Orlandi, R.; Güssow, D. H.; Jones, P. T.; Winter, G. Cloning Immunoglobulin Variable Domains for Expression by the Polymerase Chain Reaction. Proc. Natl. Acad. Sci. U. S. A. 1989, 86, 3833–3837. DOI: 10.1073/pnas.86.10.3833.
   PubMed Web of Science ®Google Scholar